A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

Journal of General Virology

Volumn 78, Issue 9, 1997, Pages 2209-2215

  Wang, Zhaohui ^a   Christensen, Neil ^b   Schiller, John T ^c   Dillner, Joakim ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; FEMALE; HUMAN; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; VIRUS CAPSID; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE;

EID: 0030964616     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-9-2209     Document Type: Article

References (23)

1. Andersson-Ellström, A., Dillner, J., Hagmar, B., Schiller, J., Sapp, M., Forssman, L. & Milsom, I. (1996a). Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sexually Transmitted Diseases 23, 234-238.
2. Andersson-Ellström, A., Hagmar, B., Johansson, B., Kalantari, M., Wärleby, B. & Forssman, L. (1996b). Human papillomavirus DNA in cervix only detected in girls after coitus. International Journal of STD & AIDS 23, 234-238.
3. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Schiller, J. T. & Orth, G. (1995). Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. Journal of Virology 69, 3959-3963.
4. Cheng, G., Icenogle, J. P., Kirnbauer, R., Hubbert, N. L., St Louis, M. E., Han, C., Svare, E. I., Lowy, D. R. & Schiller, J. T. (1995). Divergent human papillomavirus type 16 variants are serologically cross-reactive. Journal of Infectious Diseases 172, 1584-1587.
5. Christensen, N. D., Kreider, J. W., Shah, K. V. & Rando R. F. (1992). Detection of human serum antibodies that neutralize infechous human papillomavirus type 11 virions. Journal of General Virology 73, 1261-1267.
6. Christensen, N. D., Cladel, N. M. & Reed, C. A. (1995). Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology 207, 136-142.
7. Christensen, N. D., Dillner, J., Eklund, C., Carter, J. J., Reed, C. A., Cladel, N. M. & Galloway, D. A. (1996). Surface conformational and linear epitopes on HPV16 and HPV18 virus-like particles as defined by monoclonal antibodies. Virology 223, 174-184.
8. Chua, K., Wiklund, F., Lenner, P., Ångström, T., Hallmans, G., Bergman, F., Sapp, M., Schiller, J., Wadell, G., Hjerpe, A. & Dillner, J. (1996). A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in cervical smears. International Journal of Cancer 68, 54-59.
9. Dillner, J., Knekt, P., Schiller, J. T. & Hakulinen, T. (1995a). Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. British Medical Journal 311, 1346.
10. Dillner, J., Wiklund, F., Lenner, P., Eklund, C., Fredriksson-Shanazarian, V., Schiller, J. T., Hibma, M., Hallmans, G. & Stendahl, U. (1995b). Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with cervical cancer. International Journal of Cancer 60, 377-382.
11. Dillner, L., Zellbi, A., Åvall-Lundkvist, E., Heino, P., Pettersson, C. A., Hansson, B. G., Forslund, O., Grandien, M., Bistoletti, P. & Dillner, J. (1995c). Association of serum antibodies against defined epitopes of human papillomavirus L1, E2 and E7 antigens and of HPV DNA with incident cervical cancer. Cancer Detection & Prevention 19, 381-393.
12. Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., Schiller, J. T., Sapp, M. & Mårdh, P. A. (1996). Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. Journal of Infectious Diseases 173, 1394-1398.
13. Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L. & Goldberg, M., E. (1985). Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. Journal of Immunological Methods 77, 305-319.
14. Heino, P., Skyldberg, B., Lehtinen, M., Rantala, I., Hagmar, B., Kreider, J. W., Kirnbauer, R. & Dillner, J. (1995). Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. Journal of General Virology 76, 1142-1153.
15. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R. & Schiller, J. T. (1994). A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86, 494-499.
16. Lehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Kirnbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J. T. & Hakama, M. (1996). Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma. British Medical Journal 312, 537-539.
17. Roden, R., Armstrong, A., Haderer, P., Christensen, N., Hubbert, N., Douglas, R., Schiller, J. & Kirnbauer, R. (1997). Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. Journal of Virology (in press).
18. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell D. M., Rush, B. B., Scott, P. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stanton, C. K. & Manos, M. M. (1993). Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 85, 958-964.
19. Schiller, J. T. & Okun, M. M. (1996). Papillomavirus vaccines: current status and future source. Advances in Dermatology 11, 355-380.
20. Schiller, J. T. & Roden, R. B. S. (1995). Papillomavirus-like particles. Papillomavirus Report 6, 121-128.
21. Strickler, H. D., Schiffman, M. H., Eklund, C., Glass, A. G., Lörincz, A. T., Scott, D. R., Sherman, M. E., Kurman, R. J., Manos, M., Schiller, J. & Dillner, J. (1997). Characterization of HPV antibody responses to squamous intraepithelial lesions of the cervix. Cancer Epidemiology, Biomarkers & Prevention 6, 183-188.
22. Wideroff, L., Schiffman, M. H., Nonenmacher, B., Hubbert, N. K. R., Greer, C. E., Lowy, D., Lorincz, A. T., Manos, M. M., Glass, A. G., Scott, D. R., Sherman, M. E., Kurman, R. T., Buckland, J., Tarone, R. E. & Schiller, J. (1995). Evaluation of seroreactivity to HPV16 virus like-particles in an incident case-control study of cervical neoplasia. Journal of Infectious Diseases 172, 1425-1430.
23. Wikström, A., Van Doornum, G. J. J., Quint, W. G. V., Schiller, J. T. & Dillner, J. (1995). Identification of human papillomavirus seroconversions. Journal of General Virology 76, 529-539.